WRBY · Warby Parker Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $242.45M | - | $221.68M | $214.47M | $223.78M | - | $192.45M | $188.22M | $200.00M | - |
| Cost of Revenue | $111.41M | - | $101.73M | $100.87M | $97.80M | - | $87.58M | $82.84M | $86.54M | - |
| Gross Profit | $131.04M | - | $119.94M | $113.61M | $125.98M | - | $104.87M | $105.38M | $113.46M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $129.37M | - | $116.38M | $118.13M | $123.51M | - | $111.48M | $114.34M | $118.59M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $13.77M | - | - | - | $12.16M | - | - | - | $10.58M | - |
| Operating Income | $1.67M | - | $3.57M | ($4.53M) | $2.47M | - | ($6.61M) | ($8.96M) | ($5.13M) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $821.0K | - | ($125.0K) | ($789.0K) | $1.45M | - | $301.0K | $373.0K | $108.0K | - |
| Net Income | $3.18M | - | $5.87M | ($1.75M) | $3.47M | - | ($4.07M) | ($6.76M) | ($2.68M) | - |
| EPS - Basic | $0.03 | - | $0.05 | ($0.01) | $0.03 | - | ($0.03) | ($0.06) | ($0.02) | - |
| EPS - Diluted | $0.03 | - | $0.05 | ($0.01) | $0.03 | - | ($0.03) | ($0.06) | ($0.02) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $288.25M | $286.36M | $280.36M | $286.38M | $265.07M | $254.16M | $251.03M | $237.96M | $220.38M | $216.89M |
| Accounts Receivable | $1.76M | $3.29M | $1.14M | $1.14M | $1.47M | $1.95M | $1.09M | $1.21M | $1.17M | $1.78M |
| Inventory | $46.45M | $44.51M | $45.59M | $43.27M | $48.61M | $52.34M | $52.77M | $53.34M | $56.45M | $62.23M |
| Accounts Payable | $37.21M | $31.98M | $10.89M | $26.04M | $26.55M | $23.52M | $36.66M | $24.68M | $26.70M | $22.46M |
| Current Assets | $357.69M | $352.44M | $344.06M | $346.10M | $330.60M | $326.05M | $321.21M | $308.63M | $296.12M | $298.62M |
| Total Assets | $736.41M | $720.92M | $706.92M | $701.90M | $682.75M | $676.49M | $637.99M | $618.21M | $592.89M | $580.31M |
| Current Liabilities | $153.28M | $150.13M | $132.06M | $135.53M | $122.61M | $130.35M | $130.12M | $121.03M | $118.54M | $127.09M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $360.60M | $353.19M | $337.30M | $340.45M | $328.67M | $336.42M | $301.24M | $288.82M | $276.70M | $278.52M |
| Stockholders' Equity | $375.81M | $367.73M | $369.63M | $361.45M | $354.09M | $340.07M | $336.75M | $329.39M | $316.19M | $301.79M |
| Retained Earnings | ($682.40M) | ($685.58M) | ($679.63M) | ($685.50M) | ($683.75M) | ($687.22M) | ($680.34M) | ($676.27M) | ($669.51M) | ($666.83M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $24.51M | - | - | - | $29.36M | - | - | - | $19.93M | - |
| Investing Cash Flow | ($16.14M) | - | - | - | ($16.15M) | - | - | - | ($16.44M) | - |
| Financing Cash Flow | ($6.16M) | - | - | - | ($2.30M) | - | - | - | $91.0K | - |
| CapEx | $16.14M | - | - | - | $16.15M | - | - | - | $14.44M | - |
| Free Cash Flow | $8.37M | - | - | - | $13.21M | - | - | - | $5.49M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 54.0% | - | 54.1% | 53.0% | 56.3% | - | 54.5% | 56.0% | 56.7% | - |
| Operating margin | 0.7% | - | 1.6% | -2.1% | 1.1% | - | -3.4% | -4.8% | -2.6% | - |
| EBITDA margin | 6.4% | - | - | - | 6.5% | - | - | - | 2.7% | - |
| Net margin | 1.3% | - | 2.6% | -0.8% | 1.6% | - | -2.1% | -3.6% | -1.3% | - |
| Free cash flow margin | 3.5% | - | - | - | 5.9% | - | - | - | 2.7% | - |
| FCF / Net income | 2.64 | - | - | - | 3.80 | - | - | - | -2.05 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 53.4% | - | 52.5% | 55.1% | 55.2% | - | 57.9% | 60.7% | 59.3% | - |
| Effective tax rate | 20.5% | - | -2.2% | - | 29.5% | - | - | - | - | - |
| Return on assets | 0.4% | - | 0.8% | -0.2% | 0.5% | - | -0.6% | -1.1% | -0.5% | - |
| Return on equity | 0.8% | - | 1.6% | -0.5% | 1.0% | - | -1.2% | -2.1% | -0.8% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.33 | 2.35 | 2.61 | 2.55 | 2.70 | 2.50 | 2.47 | 2.55 | 2.50 | 2.35 |
| Quick ratio | 2.03 | 2.05 | 2.26 | 2.23 | 2.30 | 2.10 | 2.06 | 2.11 | 2.02 | 1.86 |
| Cash ratio | 1.88 | 1.91 | 2.12 | 2.11 | 2.16 | 1.95 | 1.93 | 1.97 | 1.86 | 1.71 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.96 | 1.96 | 1.91 | 1.94 | 1.93 | 1.99 | 1.89 | 1.88 | 1.88 | 1.92 |
| Liabilities / Assets | 0.49 | 0.49 | 0.48 | 0.49 | 0.48 | 0.50 | 0.47 | 0.47 | 0.47 | 0.48 |
| Efficiency | ||||||||||
| Asset turnover | 0.33 | - | 0.31 | 0.31 | 0.33 | - | 0.30 | 0.30 | 0.34 | - |
| Inventory turnover | 2.40 | - | 2.23 | 2.33 | 2.01 | - | 1.66 | 1.55 | 1.53 | - |
| Days sales outstanding | 3d | - | 2d | 2d | 2d | - | 2d | 2d | 2d | - |
| Days inventory outstanding | 152d | - | 164d | 157d | 181d | - | 220d | 235d | 238d | - |
| Days payable outstanding | 122d | - | 39d | 94d | 99d | - | 153d | 109d | 113d | - |
| Cash conversion cycle | 33d | - | 126d | 64d | 85d | - | 69d | 129d | 128d | - |
| Valuation | ||||||||||
| P / E | 702.3x | - | 551.6x | - | 607.7x | - | - | - | - | - |
| P / B | 7.0x | - | 9.4x | 7.4x | 6.4x | - | 5.9x | 5.9x | 5.1x | - |
| P / S | 10.9x | - | 15.6x | 12.5x | 10.2x | - | 10.3x | 10.2x | 8.1x | - |
| EV / EBITDA | 152.7x | - | - | - | 137.1x | - | - | - | 256.8x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 8.3% | - | 15.2% | 13.9% | 11.9% | - | 13.3% | 13.3% | 16.3% | - |
| Revenue CAGR (3y) | 12.1% | - | 14.2% | 17.7% | 13.5% | - | 22.7% | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 4.0% | - | 14.4% | 7.8% | 11.0% | - | 13.1% | 16.3% | 19.7% | - |
| Operating income growth (YoY) | -32.5% | - | - | 49.5% | - | - | 66.5% | 50.9% | 58.8% | - |
| Net income growth (YoY) | -8.5% | - | - | 74.1% | - | - | 76.6% | 57.5% | 75.2% | - |
| EPS growth (YoY) | 0.0% | - | - | 83.3% | - | - | 80.0% | 57.1% | 77.8% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -36.6% | - | - | - | 140.5% | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 6.1% | 8.1% | 9.8% | 9.7% | 12.0% | 12.7% | 10.6% | 9.0% | 6.7% | 5.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$875.61M totalEyewear Products$719.06M · 82.1%
Contacts Products$97.15M · 11.1%
Services And Other$55.69M · 6.4%
Shipping And Handling$3.70M · 0.4%
Peer comparison
Same SIC group: Ophthalmic Goods
Comparing Warby Parker Inc. against the 5 most active filers in the same SIC group.